Effective July 1, 2018, iuvo BioScience has closed a deal to bring Oculos Clinical Research into the iuvo family. With this transition, iuvo BioScience will now be able to offer a full suite of integrated services - preclinical / toxicology, biocompatibility, regulatory, CMC, analytical chemistry, microbiology, clinical research - for our ophthalmic clients in the medical device, pharmaceutical, biotech and diagnostic industries.

Company:

View iuvo BioScience's profile

Links:

www.iuvobioscience.com

www.oculoscr.com

Download Attachments:

https://www.contractlaboratory.com/www/uploads/media_agent/8826/iuvo Oculos Press Release FINAL July 6 2018.pdf